Published: 24 October 2020
Author(s): Yugo Yamashita, Takeshi Morimoto, Kazushige Kadota, Koh Ono, Takeshi Kimura
Section: Letter to the Editor

There are various well-known predisposing risk factors for development of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), and several studies reported that autoimmune disorder is one of important risk factors for development of VTE [1,2]. Furthermore, autoimmune disorder is thought to be a relatively strong risk factor for VTE recurrence, and extended anticoagulation therapy are recommended for prevention of VTE recurrence in patients with autoimmune disorders[3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.